| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
65,057 |
37,093 |
$3.06M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
57,104 |
31,791 |
$2.29M |
| 99215 |
Prolong outpt/office vis |
1,805 |
1,007 |
$112K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
1,109 |
645 |
$83K |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
1,901 |
1,744 |
$73K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
943 |
438 |
$48K |
| G0008 |
Administration of influenza virus vaccine |
1,485 |
1,294 |
$47K |
| 93000 |
|
1,379 |
1,206 |
$26K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
259 |
164 |
$18K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
323 |
171 |
$16K |
| 0012A |
|
838 |
479 |
$9K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
64 |
63 |
$8K |
| 0011A |
|
943 |
529 |
$8K |
| 99205 |
Prolong outpt/office vis |
79 |
28 |
$6K |
| 90686 |
|
1,294 |
835 |
$5K |
| 90674 |
|
349 |
228 |
$5K |
| 36415 |
Collection of venous blood by venipuncture |
442 |
367 |
$5K |
| 99385 |
|
75 |
38 |
$3K |
| G0009 |
Administration of pneumococcal vaccine |
91 |
87 |
$3K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
78 |
59 |
$3K |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
561 |
532 |
$3K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,358 |
689 |
$3K |
| 0001A |
|
280 |
156 |
$3K |
| 90653 |
|
56 |
56 |
$3K |
| 0002A |
|
225 |
131 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
60 |
25 |
$2K |
| 81025 |
|
475 |
298 |
$2K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
12 |
12 |
$1K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
23 |
12 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
127 |
79 |
$981.95 |
| 81002 |
|
125 |
75 |
$946.34 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
25 |
14 |
$881.58 |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
174 |
165 |
$757.98 |
| 99495 |
|
15 |
15 |
$654.39 |
| 0031A |
|
47 |
25 |
$533.20 |
| 99417 |
Prolong home eval add 15m |
13 |
12 |
$513.83 |
| 90661 |
|
64 |
48 |
$470.27 |
| G0438 |
Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit |
48 |
39 |
$455.68 |
| 90688 |
|
39 |
28 |
$445.94 |
| 99407 |
|
30 |
12 |
$404.22 |
| 3044F |
|
17 |
16 |
$389.64 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
63 |
60 |
$363.26 |
| 90662 |
|
648 |
539 |
$340.50 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
53 |
33 |
$331.10 |
| 90656 |
|
12 |
12 |
$231.00 |
| 99441 |
|
37 |
32 |
$210.74 |
| 99173 |
|
23 |
15 |
$43.81 |
| 99442 |
|
20 |
16 |
$40.00 |
| 90670 |
|
50 |
12 |
$0.10 |
| 91301 |
|
1,749 |
989 |
$0.01 |
| 91303 |
|
20 |
13 |
$0.00 |
| Q2035 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria) |
15 |
15 |
$0.00 |
| 91300 |
|
599 |
297 |
$0.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
30 |
14 |
$0.00 |